Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Pfizer appoints chief scientific officer

Dr Ole Isacson will lead the neuroscience research unit

- PMLiVE

Thornton & Ross Dermatology launches eczema consultation tool

Aims to help HCPs identify and tackle the impact of the skin condition

- PMLiVE

NHS promotes person-centred care in new dementia film

Highlights the importance of enabling people to live well with the condition

- PMLiVE

Retrophin rockets away as rare disease trial hits targets

Sparsentan has potential to become a blockbuster FSG drug, according to analysts

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Lucid Group Communications Limited

- PMLiVE

Merck closes in on first-line NSCLC label for Keytruda in US

Accelerated FDA review could see PD-1 inhibitor approved by the end of the year

Silence Therapeutics adds to leadership team

Dr Dmitry Samarsky and Dr Andy Richards join

- PMLiVE

Former Boehringer diabetes marketing VP joins Gelesis

Dr David Pass takes up the chief operating officer position

- PMLiVE

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

Lucid Group Communications Limited

How to enable each healthcare professional to fully understand your product

Read these three articles to understand how working at an individual level benefits all customers:

Anthill Agency

- PMLiVE

Biogen launches Remicade biosimilar in the UK

Flixabi provides another low-cost alternative to J&J’s biggest-selling drug

- PMLiVE

Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making

Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links